Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2017.00582
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 24, 2017
Authors
Publisher
Frontiers Media SA